Dr. Semrad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10121 Pine Ave
Truckee, CA 96161Phone+1 530-582-6450
Education & Training
- University of California Davis HealthFellowship, Hematology and Medical Oncology, 2007 - 2010
- University of California Davis HealthResidency, Internal Medicine, 2004 - 2007
- Rush Medical College of Rush University Medical CenterClass of 2004
Certifications & Licensure
- CA State Medical License 2005 - 2025
- NV State Medical License 2023 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 43 citationsRole of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical OpinionDavid J. Adelstein, Nofisat Ismaila, Jamie A. Ku, Barbara Burtness, Paul L. Swiecicki
Journal of Clinical Oncology. 2019-04-25 - 201 citationsEpidemiology of venous thromboembolism in 9489 patients with malignant glioma.Thomas J. Semrad, Robert T. O'Donnell, Theodore Wun, Helen K. Chew, Danielle J Harvey
Journal of Neurosurgery. 2007-04-01 - 58 citationsPhase I trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced malignant solid tumorsBenjamin K. Tomlinson, Jim Thomson, John S. Bomalaski, Monica Diaz, Taiwo Akande
Clinical Cancer Research. 2015-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: